Live Breaking News & Updates on Focus Capital Management
Stay updated with breaking news from Focus capital management. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tilly’s, Inc. (NYSE:TLYS – Free Report) – Investment analysts at B. Riley lowered their FY2026 EPS estimates for Tilly’s in a research note issued on Tuesday, January 9th. B. Riley analyst J. Van. Sinderen now forecasts that the specialty retailer will earn $0.26 per share for the year, down from their previous forecast of $0.36. […] ....
Insmed Incorporated (NASDAQ:INSM – Get Free Report) has been assigned an average recommendation of “Buy” from the eleven ratings firms that are presently covering the stock, MarketBeat.com reports. Eleven equities research analysts have rated the stock with a buy recommendation. The average 1-year target price among brokers that have updated their coverage on the stock […] ....
Tilly’s, Inc. (NYSE:TLYS – Get Free Report) major shareholder Fund 1 Investments, Llc purchased 6,000 shares of the business’s stock in a transaction on Tuesday, January 2nd. The stock was purchased at an average cost of $7.52 per share, for a total transaction of $45,120.00. Following the completion of the acquisition, the insider now directly […] ....
StockNews.com initiated coverage on shares of Adaptimmune Therapeutics (NASDAQ:ADAP – Free Report) in a research report sent to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Adaptimmune Therapeutics Trading Up 14.9 % Shares of NASDAQ:ADAP opened at $0.79 on Friday. Adaptimmune Therapeutics has a 1 year low of […] ....
Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 13,199 shares of the firm’s stock in a transaction on Friday, December 22nd. The shares were sold at an average price of $30.00, for a total transaction of $395,970.00. Following the completion of the transaction, the chief financial officer now owns 105,241 shares in […] ....